Evidence map›Paper›PMID 41376910›Full record

ArticleJournal of thoracic disease2025

Risk factors in psychological resilience of patients receiving chemotherapy for lung cancer.

Yi Zhao, Xuejiao Leng, Ruo Du, Zhiwei Chen

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yi Zhao *Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xuejiao Leng *Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ruo DuShanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhiwei ChenShanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung cancer patients undergoing chemotherapy often experience significant psychological stress. However, the exploration of psychological resilience, a crucial coping asset, remains limited within this population. This study aimed to assess the psychological resilience of lung cancer patients undergoing chemotherapy and to identify key factors influencing their resilience, in order to guide targeted psychological interventions, improve treatment adherence, and enhance patients' quality of life. Methods: A single-center observational cross-sectional design included 200 patients with stage IV lung cancer receiving chemotherapy with a regimen recommended according to the National Comprehensive Cancer Network (NCCN) guidelines. The assessment of psychological resilience was conducted using the Connor-Davidson Resilience Scale (CD-RISC). The study period spanned from January 2018 to January 2022 and involved hospitalized patients. The patients were categorized into low and high psychological resilience level (PRL) groups based on the median of CD-RISC scores. Additionally, participants completed questionnaires capturing demographic characteristics, Generalized Self-Efficacy Scale (GSES), Family Assessment Device (FAD), Ways of Coping Questionnaire (WCQ), Cancer Quality of Life Questionnaire (QLQ-C30) and Multidimensional Perceived Social Support Scale (MSPSS). Multivariate logistic regression analysis was employed to evaluate the impact of various factors on psychological resilience. Results: CD-RISC revealed a significant positive linear correlation with GSES (R =0.605, P<0.001), FAD (R =0.229, P=0.001), QLQ-C30 (R =-0.163, P=0.02), and MSPSS (R =0.162, P=0.02). However, no significant linear correlation was observed between CD-RISC and WCQ (P=0.86). GSES, planful problem-solving, seeking social support, and objective support were identified as significant positive factors influencing psychological resilience in lung cancer patients after chemotherapy, with GSES being the strongest predictor. Additionally, FAD and QLQ-C30 scales showed marginal significance, while demographic and lifestyle factors such as gender, age, and smoking history had no significant correlation. Conclusions: Psychological resilience, influenced by various factors, can be enhanced in individuals with lung cancer following chemotherapy through increased self-efficacy, strategic problem-solving abilities, proactive social support-seeking skills, and objective social support. Identifying and reinforcing protective factors associated with mental resilience can promote overall adjustment and well-being among patients.

Indexed as

influential factorslung cancer chemotherapymultivariate logistic regressionPsychological resiliencesocial support and self-efficacy

Identifiers

PMID41376910
PMCPMC12688486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.